Drugs for CAP, HAP, and VAP Flashcards
1
Q
amoxicillin + clavulanate
A
- inhibits bacterial cell wall synthesis and cross linking
- CAP
- broad spectrum, covers both G-POSTITIVE and GRAM-NEGATIVE
- NOT effective against pseudomonas
- administered orally
- risk of anaphylaxis, superinfection, and rash in mono
2
Q
piperacillin + tazobactam
A
- inhibits bacterial cell wall synthesis and cross linking
- CAP, HAP, or VAP
- broad spectrum, covers both G-POSTITIVE and GRAM-NEGATIVE anaerobic and anaerobic
- ACTIVE against pseudomonas
- given by IV
- risk of SJS/DRESS, nephrotoxicity, rash
3
Q
cefazolin
cephalexin
A
- β-lactams like penicillin, have same MOA
- First generation cephalosporins
- mostly G-POSITIVE coverage
4
Q
cefotetan
cefoxitin
A
- β-lactams like penicillin, have same MOA
- Second generation cephalosporins
- moderate G-NEGATIVE and less G-POSITIVE coverage
5
Q
ceftriaxone (IV)
cefpodoxime (oral)
cefditoren (oral)
A
- β-lactams like penicillin, have same MOA
- Third generation cephalosporins
- G-POSITIVE and more G-NEGATIVE coverage, d/t increased penetration through outer membrane
- CEFTRIAXONE is not excreted by kidney, so dosage adjustment is NOT needed in renal impairment
6
Q
cefepime (IV)
A
- β-lactams like penicillin, have same MOA
- Fourth generation cephalosporins
- more G-POSITIVE coverage
7
Q
ceftaroline
A
- β-lactams like penicillin, have same MOA
- Fifth generation cephalosporins
8
Q
doxycycline
A
- Tetracycline: binds to 30s of ribosome and prevents growth of peptide chain.
- Bacteriostatic
- CAP (use with β-lactam)
- risk of TOOTH DISCOLORATION IN CHILDREN
9
Q
azithromycin
A
- Macrolide: bind to 50s of ribosome and prevent elongation of peptide
- CAP
- Cover aerobic and anaerobic G-POSITIVE, not effective against G-NEGATIVE (except pasturella, haemophilus, and neisseria)
- does not inhibit CYP450
10
Q
clarithromycin
A
- Macrolide: bind to 50s of ribosome and prevent elongation of peptide
- CAP
- Cover aerobic and anaerobic G-POSITIVE, not effective against G-NEGATIVE (except pasturella, haemophilus, and neisseria)
- INHIBITS CYP450
11
Q
erythromycin
A
- Macrolide: bind to 50s of ribosome and prevent elongation of peptide
- CAP
- Cover aerobic and anaerobic G-POSITIVE, not effective against G-NEGATIVE (except pasturella, haemophilus, and neisseria)
- INHIBITS CYP450
- risk of epigastric pain
12
Q
levofloxacin
A
- Respiratory fluoroquinolones
- broad spectrum, active against both G-POSITIVE and G-NEGATIVE
- SHOULD BE RESERVED FOR SERIOUS INFECTIONS
- risk of TENDON RUPTURE
13
Q
gemifloxacin
A
- Respiratory fluoroquinolones
- broad spectrum, active against both G-POSITIVE and G-NEGATIVE
- SHOULD BE RESERVED FOR SERIOUS INFECTIONS
- risk of TENDON RUPTURE
14
Q
moxifloxacin
A
- Respiratory fluoroquinolones
- broad spectrum, active against both G-POSITIVE and G-NEGATIVE
- SHOULD BE RESERVED FOR SERIOUS INFECTIONS
- risk of TENDON RUPTURE
15
Q
vancomycin
A
- Prevents cell wall synthesis
- given IV for serious infections
- risk of Red Man syndrome